Skip to content

SIMABS

Active Public limited companyfounded 2019active for 7 yearsAgoralaan Abis, 3590 DiepenbeekKBO/BCE: BE 0732.709.096 #7 company by total assets in Diepenbeek, Manufacturing sector
SIMABS
Follow ReportCompare

Board

4 directors, no change since January 2026
Chemsciences Middle East Fzc
Director, permanent representative Amit Tibrewala
current term since 16-12-2025
listed in the 2025 annual accounts, filed on 30-07-2026
QbD Growth BV
Director, permanent representative Bart Van Acker
since 16-12-2025
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 30-07-2026
VANDECRUYS Amber
Director
since 16-12-2025
listed in the 2025 annual accounts, filed on 30-07-2026
Chemscienses Middle East Fzc
Director
appointed by deed of 05-01-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De vennootschap zal geldig worden vertegenwoordigd tegenover derden en in rechte wanneer ten minste twee (2) bestuurders gezamenlijk…”
deed of 20-10-2023
Permanent representatives 2
Amit Tibrewala
Permanent representative, for Chemsciences Middle East Fzc
appointed by deed of 05-09-2025
Bart Van Acker
Permanent representative, for QbD Growth
appointed by deed of 05-01-2026

Office holders in the KBO →

Mandates through the years

11 names, the dashed line is today
Chemsciences Middle East Fzc
Director
QbD Growth
Director
VANDECRUYS Amber
Director
Chemscienses Middle East Fzc
Director
EYE-TEC
Director
Metatron Holding
Class B director
Oak Projects
Director
Pilot Biologix
Director
Quality for You
Director
Vandermarliere Nicolas
Class B director
JTR CONSULTING
Director
BoardEarliermandate already running before its first mention
Mandates as a list
  • Chemsciences Middle East Fzc
    • Director, appointed by deed of 05-09-2025, still in office
  • QbD Growth
    • Director, from 16-12-2025 to date
  • VANDECRUYS Amber
    • Director, from 16-12-2025 to date
  • Chemscienses Middle East Fzc
    • Director, appointed by deed of 05-01-2026, still in office
    • Director, until 05-01-2026
  • EYE-TEC
    • Director, from 20-08-2019 to 05-01-2026
  • Metatron Holding
    • Class B director, from 25-09-2023 to 05-01-2026
  • Oak Projects
    • Director, from 20-08-2019 to 05-01-2026
  • Pilot Biologix
    • Director, from 20-08-2019 to 05-01-2026
  • Quality for You
    • Director, from 20-08-2019 to 05-01-2026
  • Vandermarliere Nicolas
    • Class B director, from 25-09-2023 to 05-01-2026
  • JTR CONSULTING
    • Director, from 20-08-2019 to 03-02-2022

Control

Shareholder
QbD Growth
Equity €98.9m
Profit €361,343 in 2025 (loss €274,471 in 2024)
37.08%
This company
SIMABS
Equity €1.0m
Loss €1.5m in 2025

and 2 other shareholders

Capital

Capital
€6,221,600
Shares
183,672,625 in the deed of 20-10-2023 and 3 later capital increases
Contribution per share
€0.03
Equity per share
€0.01 in 2025
Source
deed of 13-03-2026

Owners through the years

as the annual accounts name them
QbD Growth
37.08%
37.08%
Pilot Biologix
20%24%18.54%
18.54%
Oak Projects
20%5.33%2.91%
2.91%
Metatron Holding
10.59%
10.59% until 2024
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 05-01-2026 (in Dutch)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 5 directors
At most 7 directors
Term of at most 6 years
deed of 13-03-2026 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
30 June at 14:00
deed of 05-01-2026 (in Dutch)

Shareholders

3 owners

Owners 3

Capital transactions

Shareholders according to the deeds
At incorporation deed of 22-08-2019 ↗
Capital over time
  1. 13-03-2026 Capital increase of €1,500,000 · to €6,221,600 · 20,280,378 new shares · in cash
  2. 05-01-2026 Capital increase of €1,335,000 · to €3,241,600 · 18,049,537 new shares at €0.07 per share
  3. 05-01-2026 Capital increase of €1,500,000 · to €5,771,600 · 20,280,378 new shares
  4. 20-10-2023 Capital increase of €831,600 · to €1,906,600 · 36,728,999 new shares, 29.4% of the 125,062,332 shares after the increase · in cash
  5. 03-02-2022 Capital increase of €575,000 · to €1,075,000 · 38,333,333 new shares · in cash
  6. 03-11-2020 Capital increase of €400,000 · to €500,000 · 40,000,000 new shares · in cash
  7. 22-08-2019 Incorporation · €100,000 · 10,000,000 shares

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure